Inhibition of lncRNA NEAT1 sensitizes medulloblastoma cells to cisplatin through modulating the miR-23a-3p-glutaminase (GLS) axis
出版年份 2022 全文链接
标题
Inhibition of lncRNA NEAT1 sensitizes medulloblastoma cells to cisplatin through modulating the miR-23a-3p-glutaminase (GLS) axis
作者
关键词
-
出版物
Bioengineered
Volume 13, Issue 3, Pages 7670-7682
出版商
Informa UK Limited
发表日期
2022-03-22
DOI
10.1080/21655979.2021.2008695
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
- (2021) Jing Guo et al. BMC CANCER
- lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis
- (2021) Lin Zhu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The Role of Long Non-coding RNAs in Cancer Metabolism: A Concise Review
- (2020) Soudeh Ghafouri-Fard et al. Frontiers in Oncology
- Delivery of Long Non-coding RNA NEAT1 by Peripheral Blood Monouclear Cells-Derived Exosomes Promotes the Occurrence of Rheumatoid Arthritis via the MicroRNA-23a/MDM2/SIRT6 Axis
- (2020) Yujun Rao et al. Frontiers in Cell and Developmental Biology
- Medulloblastoma
- (2019) Paul A. Northcott et al. Nature Reviews Disease Primers
- The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
- (2019) Peter Vaupel et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression
- (2019) Fei Ding et al. Cancer Cell International
- Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies
- (2018) Jun Wang et al. Annual Review of Neuroscience
- The clinical importance of medulloblastoma extent of resection: a systematic review
- (2018) Eric M. Thompson et al. JOURNAL OF NEURO-ONCOLOGY
- Glutamine metabolism, the Achilles heel for medulloblastoma tumor
- (2018) Maria Victoria Niklison-Chirou Cell Death & Disease
- Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia
- (2018) Chen Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis
- (2018) Fubo Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Medulloblastoma: Molecular Classification-Based Personal Therapeutics
- (2017) Tenley C. Archer et al. Neurotherapeutics
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis
- (2016) Chao Yang et al. Oncotarget
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started